Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

2024 Vol. 42, No. 8

Cover Catalogue
Reviews
Advances in chiral analysis and stereoselective pharmacokinetics of dihydropyridine calcium antagonists
ZHANG Yixin, GUAN Xinyi, WANG Boning, WEN Jun, HONG Zhanying
2024, 42(8): 319-324. doi: 10.12206/j.issn.2097-2024.202308062
Abstract(10775) HTML (2156) PDF (1022KB)(50)
Abstract:
Chiral drugs are closely related to the safety and effectiveness of drug use. Most dihydropyridine drugs have chiral carbon atoms, which are used as racemes and produce stereoselective disposal characteristics after entering the body, and may affect ...
Original articles
Exploration of the antidepressant mechanism of Baihe Zhimu decoction based on NLRP1 inflammasome
YUE Chunhua, BEN Yongguang, WANG Haiqiao
2024, 42(8): 325-333. doi: 10.12206/j.issn.2097-2024.202401033
Abstract(9466) HTML (1736) PDF (1805KB)(18)
Abstract:
Objective  To study the mechanism of antidepressant effect of Baihe Zhimu decoction based on NLRP1 inflammasome.   Methods  A chronic unpredictable mild stress(CUMS)induced depression mouse model was constructed. C57BL/6J mice were randomly divide...
Pharmacoeconomic evaluation of pembrolizumab versus platinum chemotherapy as first-line treatment in advanced non-small cell lung cancer
SONG Yutong, XIA Derun, GU Heng, TANG Shaowen, YI Honggang, WO Hongmei
2024, 42(8): 334-340. doi: 10.12206/j.issn.2097-2024.202303023
Abstract(8963) HTML (2793) PDF (1217KB)(223)
Abstract:
Objective  To make the cost-effectiveness analysis of pembrolizumab and platinum chemotherapy as the first-line treatment for advanced non-small cell lung cancer (NSCLC) in the population with tumor proportion score (TPS) ≥ 1% of PD-L1, and provide ...
Determination and pharmacokinetics investigation of prodrugs of paclitaxel fatty acid esters in mouse plasma by UPLC-MS/MS
CHEN Bingchen, TONG Dafeng, WAN Miao, YAN Feihu, YAO Jianzhong
2024, 42(8): 341-345. doi: 10.12206/j.issn.2097-2024.202404082
Abstract(6581) HTML (1761) PDF (981KB)(20)
Abstract:
Objective  To establish an UPLC-MS/MS method for determinating content of three paclitaxel fatty acid esters such as paclitaxel myristate (PTX-MA), paclitaxel palmitate (PTX-PA) and paclitaxel myristate (PTX-SA) in mouse plasma, and preliminarily in...
Sedative and hypnotic effects and mechanism of Yening Capsules on mice
LI Qing, GUO Yiyin, CHEN Ying, QU Falin, DONG Wenshen, GE Yu
2024, 42(8): 346-349. doi: 10.12206/j.issn.2097-2024.202211047
Abstract(5798) HTML (1464) PDF (877KB)(12)
Abstract:
Objective  To study the sedative and hypnotic effects of Yening Capsules and investigate its bioactive mechanism in mice.   Methods  The mice were randomly divided into control group, estazolam group (0.8 mg/kg), low, medium and high-dose Yening C...
Prediction of characteristic chromatogram for Abri Herba based on network pharmacology and molecular docking
ZHANG Chengzhong, ZHU Xueyan, BU Qitao, WANG Hongrui, HUANG Baokang
2024, 42(8): 350-358. doi: 10.12206/j.issn.2097-2024.202303048
Abstract(10307) HTML (2148) PDF (3585KB)(31)
Abstract:
Objective  To predict the potential Q-markers of Abri Herba based on network pharmacology and molecular docking and establish a quality control characteristic.   Methods  The network relationship of “Abri Herba - component - target - pathway” was ...
Pharmacy Administration
Comparative study on pharmaceutical emergency approval systems in China and other countries
CUI Lijun, CHEN Yanting, FEI Yonghe, CHEN Jing
2024, 42(8): 359-364. doi: 10.12206/j.issn.2097-2024.202310015
Abstract(4410) HTML (913) PDF (884KB)(20)
Abstract:
Objective  To explore the ideas and measures to further optimize China’s drug emergency approval system by comparing the drug emergency approval systems in China and other countries.   Methods  The current situation of China’s drug emergency appro...